Have just been rejected for a La Jolla phase 3 trial for Ifn previous treatment failures. The coordinator took lots of info from me and then told me co-infection patients were not allowed despite the fact that the trial listing was for failed or non-responder patients and HIV co-infection was not listed as a disqualifying condition. I have exhausted all options, been on Ifn riba for 10 years now, intermittent, repeated rebound, until the bone marrow has collapsed. Last treatment had me on neupogen constantly which causes it's own harmful side effects, with constant low white count. I am unable to tolerate any of the HIV meds as they are for me all hepatotoxic within a matter of days, probabaly a result of the HCV. Consequently the T cell count is dropping, at about 500 now. Below that the HCV accelerates, and 5 biopsies have returned stages 1, 2 and 3 fibrosis scores, so the histology is all over the place. Looks like I'm soon to be pushing up daisies. Not soon enough. Torturous really. All of it. Could be worse, I could have Parkinsons, MS or Alzheimers...or all three. Or be the guy who had no shoes AND no feet. Somehow that old addage doesn't cheer me...
They tell me the HCV protease inhibitors are fast tracked, a couple, maybe just one, and to-market time looks like 6 years from inception! If that's fast tracked I'd hate to see the slow boat to China. HIV PIs were something less than 5 years from inception to market.
So, anybody know of any co-infection studies (which I probably won't be accepted for anyway due to the conditon in which Ifn has left me and because my luck ran out some time back along with Nixon's) ? Seems with some 30 to 40% of HIV patients also HCV co-infected there'd be at least some investigation into this population. That makes about 300 to 400K in the U.S. alone.